SCHEMBL8683134

SCHEMBL8683134

CCOC(=O)ON1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
SOAT1 P35610 1/20 0.46
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 2/20 0.37
HSD17B10 Q99714 1/20 0.37
HPGD P15428 2/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
THRB P10828 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 2/20 0.36
ALOX15 P16050 1/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8681188 1.00 ALDH1A1 (0.50) ALDH1A1SOAT1TSHRPOLBHTT
SCHEMBL8681288 0.98 ALDH1A1 (0.48) ALDH1A1SOAT1TSHRPOLBHTT
SCHEMBL8681250 0.83 HPGD (0.39) ALDH1A1TSHRPOLBSMN1; SMN2LMNA
SCHEMBL8681192 0.83 HPGD (0.39) ALDH1A1TSHRPOLBSMN1; SMN2LMNA
SCHEMBL2322368 0.82 ALDH1A1 (0.38) ALDH1A1SOAT1POLBLMNAHSD17B10
SCHEMBL2143739 0.82 ALDH1A1 (0.44) ALDH1A1SOAT1TSHRPOLBHTT
SCHEMBL8706686 0.82 HPGD (0.41) ALDH1A1TSHRPOLBSMN1; SMN2LMNA
SCHEMBL8850898 0.80 ALDH1A1 (0.43) ALDH1A1SOAT1TSHRPOLBHTT
SCHEMBL8683226 0.80 ALDH1A1 (0.45) ALDH1A1TSHRPOLBSMN1; SMN2LMNA
SCHEMBL8681141 0.79 L3MBTL1 (0.47) ALDH1A1TSHRPOLBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed